Search results
Author(s):
Jeff Healey
Added:
1 year ago
In this short interview, Dr Jeff Healey (McMaster University, Hamilton, CA) talks about the key data from the ATLAS (Avoid Transvenous Leads in Appropriate Subjects) trial (NCT02881255).The aim of the study was to compare standard, single chamber transvenous ICD (TV-ICD) to sub-cutaneous ICD (S-ICD) (Boston Scientific EMBLEM) in occurrence of perioperative and long term device related…
View more
Author(s):
Tom Brouwer
Added:
5 years ago
Dr Tom Brouwer discusses aprospective, blinded evaluation of anovel filter designed to reduce inappropriate shocks by the subcutaneous implantable defibrillator.
Filmed by Radcliffe Cardiology on-site at HRS 2018 in Boston, US.
View more
Author(s):
Charles D Swerdlow
Added:
3 years ago
Balanced Evaluation of the ICD
Although better known for his transformative contributions to arrhythmia mechanisms, mapping and ablation, Dr Josephson participated in investigational studies of the first implantable defibrillator2,3 and served as a principal investigator for the MUSTT (Multicenter Unsustained Tachycardia Trial) foundational trial of primary-prevention ICD therapy.4 In one of the…
View more
Author(s):
Amar Trivedi
,
Bradley P Knight
Added:
3 years ago
Hypertrophic cardiomyopathy (HCM), a genetic sarcomeric disorder associated with myocyte disarray and scar deposition, is intimately linked to sudden cardiac death (SCD) due to malignant ventricular arrhythmias. In the first modern published description of the disease in 1958, Dr Donald Teare describes the case of a 14-year-old male who collapsed while being chased around his school’s playground…
View more
Author(s):
Francesco Zanon
Added:
6 years ago
Afzal Sohaib interviews Francesco Zanon from Ospedale Santa Maria Della Misericordia, Rovigo, IT on his research onDetecting Long-Term Complications after ICD Replacement.
Filmed by Radcliffe Cardiology on-site at EHRA 2017.
View more
Author(s):
Niraj Varma
Added:
5 years ago
Dr Niraj Varma discusses optimisation of ICD programming in practice.
Fillmed by Radcliffe Cardiology on-site at EHRA 2018 in Barcelona, ES
View more
Author(s):
Paolo Della Bella
Added:
2 years ago
In this short interview from ACC.22, Dr Paolo Della Bella (San Raffaele University-Hospital, IT) joins us to discuss the findings of the PARTITA trial (NCT01547208). The aim of this study was to determine whether the burden of ventricular tachycardia correlates with ICD shock therapies and if the timing of VT ablation affects patient prognosis.
Discussion Points:
Rationale behind this trial
…
View more
Author(s):
Michael R Gold
Added:
6 years ago
Michael Gold from Medical University of South Carolina, Charleston, SA, S-ICD Registry: Subcutaneous ICD (S-ICD) Post-market approval study.
Filmed by Radcliffe Cardiology on-site at HRS 2017.
View more
Author(s):
Pier D Lambiase
Added:
2 years ago
Prof Pier Lambiase (UCL & Barts Heart Centre, London, UK) discusses the long-term efficacy and final outcomes of the subcutaneous implantable cardioverter-defibrillator (S-ICD) registry. The registry was conducted at 50 centres worldwide, in patients requiring an ICD for the treatment of ventricular tachyarrhythmias.
Questions
1. What are the benefits of S-ICDs compared to ICDs?
2. What is the S…
View more